Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$216.64 - $362.52 $14 Million - $23.5 Million
-64,800 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$205.93 - $447.23 $2.04 Million - $4.43 Million
-9,900 Reduced 13.25%
64,800 $17.7 Million
Q2 2021

Aug 16, 2021

BUY
$113.32 - $241.49 $8.47 Million - $18 Million
74,700 New
74,700 $16.7 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Shanda Asset Management Holdings LTD Portfolio

Follow Shanda Asset Management Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.